Mirae Asset Global Investments Co., Ltd. Sage Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,419 shares of SAGE stock, worth $21,190. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,419
Previous 2,057
17.6%
Holding current value
$21,190
Previous $16,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding SAGE
# of Institutions
219Shares Held
49.9MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$45.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$44.5 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$39.2 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$23.9 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$18.3 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $521M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...